Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Современные аспекты профилактики ишемического инсульта в практике интерниста
Современные аспекты профилактики ишемического инсульта в практике интерниста
Шишкова В.Н. Современные аспекты профилактики ишемического инсульта в практике интерниста Consilium Medicum. 2018; 20 (12): 80–85. DOI: 10.26442/20751753.2018.12.180158
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Ишемический инсульт (ИИ) является сложным многофакторным заболеванием с наследственным компонентом, биохимическими, метаболическими, воспалительными, коагуляционными и гемодинамическими факторами, а также влиянием условий окружающей среды в местах проживания. Оценка вклада разных факторов риска в прогноз развития первого и повторного ИИ может служить основой для развития персонализированных программ первичной и вторичной профилактики ИИ, особенно у пациентов с высоким риском развития данной патологии. Вопросы проведения первичной и вторичной профилактики инсульта являются общими для неврологов, кардиологов, эндокринологов, терапевтов и, конечно, врачей общей практики.
Ключевые слова: ишемический инсульт, профилактика.
Ключевые слова: ишемический инсульт, профилактика.
________________________________________________
Key words: ischemic stroke, prevention.
Полный текст
Список литературы
1. Инсульт. Руководство для врачей. Под ред. С.В.Котова, Л.В.Стаховской. М.: Издательство МИА, 2013. / Insul't. Rukovodstvo dlia vrachei. Pod red. S.V.Kotova, L.V.Stakhovskoi. M.: Izdatel'stvo MIA, 2013. [in Russian]
2. O’Donnell M, Xavier D, Liu L et al. INTERSTROKE Investigators. Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112–23.
3. Christiansen C, Gerds T, Olesen J et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace 2016; 18: 1689–97.
4. Авдонина М.А., Наседкина Т.В., Иконникова А.Ю. и др. Исследование ассоциации полиморфных маркеров генов F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 с ишемическим инсультом среди русского населения Центральной России. Журн. неврологии и психиатрии им. С.С.Корсакова. 2012; 112 (2): 51–4. / Avdonina M.A., Nasedkina T.V., Ikonnikova A.Iu. i dr. Issledovanie assotsiatsii polimorfnykh markerov genov F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 s ishemicheskim insul'tom sredi russkogo naseleniia Tsentral'noi Rossii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2012; 112 (2): 51–4. [in Russian]
5. Шишкова В.Н., Ременник А.Ю., Валяева В.Н. и др. Изучение ассоциаций полиморфных вариантов генов липидного и углеводного обменов, сосудистого воспаления и нейротрансмиттерных систем с развитием первого ишемического инсульта. Кардиоваск. терапия и профилактика. 2017; 16 (5): 27–33. / Shishkova V.N., Remennik A.Iu., Valiaeva V.N. i dr. Izuchenie assotsiatsii polimorfnykh variantov genov lipidnogo i uglevodnogo obmenov, sosudistogo vospaleniia i neirotransmitternykh sistem s razvitiem pervogo ishemicheskogo insul'ta. Kardiovask. terapiia i profilaktika. 2017; 16 (5): 27–33. [in Russian]
6. Шишкова В.Н., Адашева Т.В, Ременник А.Ю. и др. Прогностическая значимость клинико-антропометрических, биохимических, метаболических, сосудисто-воспалительных и молекулярно-генетических маркеров в развитии первого ишемического инсульта. Журн. неврологии и психиатрии им. С.С.Корсакова. 2018; 2: 4–11. / Shishkova V.N., Adasheva T.V, Remennik A.Iu. i dr. Prognosticheskaia znachimost' kliniko-antropometricheskikh, biokhimicheskikh, metabolicheskikh, sosudisto-vospalitel'nykh i molekuliarno-geneticheskikh markerov v razvitii pervogo ishemicheskogo insul'ta. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2018; 2: 4–11. [in Russian]
7. Шишкова В.Н., Адашева Т.В., Ременник А.Ю. и др. Предикторы развития повторного ишемического инсульта. Врач. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 / Shishkova V.N., Adasheva T.V., Remennik A.Iu. i dr. Prediktory razvitiia povtornogo ishemicheskogo insul'ta. Vrach. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 [in Russian]
8. Фонякин А.В., Гераскина Л.А. Профилактика ишемического инсульта. Рекомендации по антитромботической терапии. Под ред. З.А.Суслиной. М.: ИМА-Пресс, 2014. / Foniakin A.V., Geraskina L.A. Profilaktika ishemicheskogo insul'ta. Rekomendatsii po antitromboticheskoi terapii. Pod red. Z.A.Suslinoi. M.: IMA-Press, 2014. [in Russian]
9. Furie K, Kasner S, Adams R et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2011; 42: 227–76.
10. Goldstein L, Bushnell Ch, Adams R et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–84.
11. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. The European Stroke Organization (ESO), 2008. http://www.eso-stroke.org
12. Jauch E, Saver J, Adams H et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke 2013; 44: 870–947.
14. Kernan W et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160–236.
15. Intercollegiate Stroke Working Party. National clinical guideline for stroke, 4th ed. London: Royal College of Physicians, 2012.
16. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34 (11): 2741–8.
17. Клинические рекомендации «Диагностика и лечение артериальной гипертензии» Российского медицинского общества по артериальной гипертонии, 2013. / Klinicheskie rekomendatsii “Diagnostika i lechenie arterial'noi gipertenzii” Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii, 2013. [in Russian]
18. Рекомендации ЕОК/ЕОА по диагностике и лечению дислипидемий 2016. Рос. кардиол. журн. 2017; 5 (145): 7–77. / Rekomendatsii EOK/EOA po diagnostike i lecheniiu dislipidemii 2016. Ros. kardiol. zhurn. 2017; 5 (145): 7–77. [in Russian]
19. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation, 2011.
20. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 8-й вып. Сахарный диабет. 2017; 20 (1S): 1–112. / Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 8-i vyp. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
21. Stamler J, Vaccaro O, Neaton J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16 (2): 434–44.
22. Шишкова В.Н. Взаимосвязь развития метаболических и когнитивных нарушений у пациентов с сахарным диабетом, предиабетом и метаболическим синдромом. Неврология и Ревматология (Прил. к журн. Consilium Medicum). 2010; 1: 36–43. / Shishkova V.N. Vzaimosviaz' razvitiia metabolicheskikh i kognitivnykh narushenii u patsientov s sakharnym diabetom, prediabetom i metabolicheskim sindromom. Neurology and Rheumatology (Suppl. Consilium Medicum). 2010; 1: 36–43. [in Russian]
23. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 17 (3).
24. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in atrial fibrillation: a systematic review. Neurology 2007; 69 (6): 546–54.
25. Camm A, Lip G, de Caterina R et al. 2012 focused up date of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719–47.
26. Диагностика и лечение фибрилляций предсердий. Рекомендации РКО, ВНОА и АССХ, 2017. / Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh, 2017. [in Russian]
2. O’Donnell M, Xavier D, Liu L et al. INTERSTROKE Investigators. Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112–23.
3. Christiansen C, Gerds T, Olesen J et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace 2016; 18: 1689–97.
4. Avdonina M.A., Nasedkina T.V., Ikonnikova A.Iu. i dr. Issledovanie assotsiatsii polimorfnykh markerov genov F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 s ishemicheskim insul'tom sredi russkogo naseleniia Tsentral'noi Rossii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2012; 112 (2): 51–4. [in Russian]
5. Shishkova V.N., Remennik A.Iu., Valiaeva V.N. i dr. Izuchenie assotsiatsii polimorfnykh variantov genov lipidnogo i uglevodnogo obmenov, sosudistogo vospaleniia i neirotransmitternykh sistem s razvitiem pervogo ishemicheskogo insul'ta. Kardiovask. terapiia i profilaktika. 2017; 16 (5): 27–33. [in Russian]
6. Shishkova V.N., Adasheva T.V, Remennik A.Iu. i dr. Prognosticheskaia znachimost' kliniko-antropometricheskikh, biokhimicheskikh, metabolicheskikh, sosudisto-vospalitel'nykh i molekuliarno-geneticheskikh markerov v razvitii pervogo ishemicheskogo insul'ta. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2018; 2: 4–11. [in Russian]
7. Shishkova V.N., Adasheva T.V., Remennik A.Iu. i dr. Prediktory razvitiia povtornogo ishemicheskogo insul'ta. Vrach. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 [in Russian]
8. Foniakin A.V., Geraskina L.A. Profilaktika ishemicheskogo insul'ta. Rekomendatsii po antitromboticheskoi terapii. Pod red. Z.A.Suslinoi. M.: IMA-Press, 2014. [in Russian]
9. Furie K, Kasner S, Adams R et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2011; 42: 227–76.
10. Goldstein L, Bushnell Ch, Adams R et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–84.
11. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. The European Stroke Organization (ESO), 2008. http://www.eso-stroke.org
12. Jauch E, Saver J, Adams H et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke 2013; 44: 870–947.
14. Kernan W et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160–236.
15. Intercollegiate Stroke Working Party. National clinical guideline for stroke, 4th ed. London: Royal College of Physicians, 2012.
16. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34 (11): 2741–8.
17. Klinicheskie rekomendatsii “Diagnostika i lechenie arterial'noi gipertenzii” Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii, 2013. [in Russian]
18. Rekomendatsii EOK/EOA po diagnostike i lecheniiu dislipidemii 2016. Ros. kardiol. zhurn. 2017; 5 (145): 7–77. [in Russian]
19. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation, 2011.
20. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 8-i vyp. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
21. Stamler J, Vaccaro O, Neaton J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16 (2): 434–44.
22. Shishkova V.N. Vzaimosviaz' razvitiia metabolicheskikh i kognitivnykh narushenii u patsientov s sakharnym diabetom, prediabetom i metabolicheskim sindromom. Neurology and Rheumatology (Suppl. Consilium Medicum). 2010; 1: 36–43. [in Russian]
23. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 17 (3).
24. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in atrial fibrillation: a systematic review. Neurology 2007; 69 (6): 546–54.
25. Camm A, Lip G, de Caterina R et al. 2012 focused up date of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719–47.
26. Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh, 2017. [in Russian]
2. O’Donnell M, Xavier D, Liu L et al. INTERSTROKE Investigators. Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112–23.
3. Christiansen C, Gerds T, Olesen J et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace 2016; 18: 1689–97.
4. Авдонина М.А., Наседкина Т.В., Иконникова А.Ю. и др. Исследование ассоциации полиморфных маркеров генов F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 с ишемическим инсультом среди русского населения Центральной России. Журн. неврологии и психиатрии им. С.С.Корсакова. 2012; 112 (2): 51–4. / Avdonina M.A., Nasedkina T.V., Ikonnikova A.Iu. i dr. Issledovanie assotsiatsii polimorfnykh markerov genov F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 s ishemicheskim insul'tom sredi russkogo naseleniia Tsentral'noi Rossii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2012; 112 (2): 51–4. [in Russian]
5. Шишкова В.Н., Ременник А.Ю., Валяева В.Н. и др. Изучение ассоциаций полиморфных вариантов генов липидного и углеводного обменов, сосудистого воспаления и нейротрансмиттерных систем с развитием первого ишемического инсульта. Кардиоваск. терапия и профилактика. 2017; 16 (5): 27–33. / Shishkova V.N., Remennik A.Iu., Valiaeva V.N. i dr. Izuchenie assotsiatsii polimorfnykh variantov genov lipidnogo i uglevodnogo obmenov, sosudistogo vospaleniia i neirotransmitternykh sistem s razvitiem pervogo ishemicheskogo insul'ta. Kardiovask. terapiia i profilaktika. 2017; 16 (5): 27–33. [in Russian]
6. Шишкова В.Н., Адашева Т.В, Ременник А.Ю. и др. Прогностическая значимость клинико-антропометрических, биохимических, метаболических, сосудисто-воспалительных и молекулярно-генетических маркеров в развитии первого ишемического инсульта. Журн. неврологии и психиатрии им. С.С.Корсакова. 2018; 2: 4–11. / Shishkova V.N., Adasheva T.V, Remennik A.Iu. i dr. Prognosticheskaia znachimost' kliniko-antropometricheskikh, biokhimicheskikh, metabolicheskikh, sosudisto-vospalitel'nykh i molekuliarno-geneticheskikh markerov v razvitii pervogo ishemicheskogo insul'ta. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2018; 2: 4–11. [in Russian]
7. Шишкова В.Н., Адашева Т.В., Ременник А.Ю. и др. Предикторы развития повторного ишемического инсульта. Врач. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 / Shishkova V.N., Adasheva T.V., Remennik A.Iu. i dr. Prediktory razvitiia povtornogo ishemicheskogo insul'ta. Vrach. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 [in Russian]
8. Фонякин А.В., Гераскина Л.А. Профилактика ишемического инсульта. Рекомендации по антитромботической терапии. Под ред. З.А.Суслиной. М.: ИМА-Пресс, 2014. / Foniakin A.V., Geraskina L.A. Profilaktika ishemicheskogo insul'ta. Rekomendatsii po antitromboticheskoi terapii. Pod red. Z.A.Suslinoi. M.: IMA-Press, 2014. [in Russian]
9. Furie K, Kasner S, Adams R et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2011; 42: 227–76.
10. Goldstein L, Bushnell Ch, Adams R et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–84.
11. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. The European Stroke Organization (ESO), 2008. http://www.eso-stroke.org
12. Jauch E, Saver J, Adams H et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke 2013; 44: 870–947.
14. Kernan W et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160–236.
15. Intercollegiate Stroke Working Party. National clinical guideline for stroke, 4th ed. London: Royal College of Physicians, 2012.
16. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34 (11): 2741–8.
17. Клинические рекомендации «Диагностика и лечение артериальной гипертензии» Российского медицинского общества по артериальной гипертонии, 2013. / Klinicheskie rekomendatsii “Diagnostika i lechenie arterial'noi gipertenzii” Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii, 2013. [in Russian]
18. Рекомендации ЕОК/ЕОА по диагностике и лечению дислипидемий 2016. Рос. кардиол. журн. 2017; 5 (145): 7–77. / Rekomendatsii EOK/EOA po diagnostike i lecheniiu dislipidemii 2016. Ros. kardiol. zhurn. 2017; 5 (145): 7–77. [in Russian]
19. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation, 2011.
20. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 8-й вып. Сахарный диабет. 2017; 20 (1S): 1–112. / Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 8-i vyp. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
21. Stamler J, Vaccaro O, Neaton J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16 (2): 434–44.
22. Шишкова В.Н. Взаимосвязь развития метаболических и когнитивных нарушений у пациентов с сахарным диабетом, предиабетом и метаболическим синдромом. Неврология и Ревматология (Прил. к журн. Consilium Medicum). 2010; 1: 36–43. / Shishkova V.N. Vzaimosviaz' razvitiia metabolicheskikh i kognitivnykh narushenii u patsientov s sakharnym diabetom, prediabetom i metabolicheskim sindromom. Neurology and Rheumatology (Suppl. Consilium Medicum). 2010; 1: 36–43. [in Russian]
23. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 17 (3).
24. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in atrial fibrillation: a systematic review. Neurology 2007; 69 (6): 546–54.
25. Camm A, Lip G, de Caterina R et al. 2012 focused up date of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719–47.
26. Диагностика и лечение фибрилляций предсердий. Рекомендации РКО, ВНОА и АССХ, 2017. / Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh, 2017. [in Russian]
________________________________________________
2. O’Donnell M, Xavier D, Liu L et al. INTERSTROKE Investigators. Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112–23.
3. Christiansen C, Gerds T, Olesen J et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. Europace 2016; 18: 1689–97.
4. Avdonina M.A., Nasedkina T.V., Ikonnikova A.Iu. i dr. Issledovanie assotsiatsii polimorfnykh markerov genov F12, PON1, PON2, NOS2, PDE4D, HIFla, GPIba, CYP11B2 s ishemicheskim insul'tom sredi russkogo naseleniia Tsentral'noi Rossii. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2012; 112 (2): 51–4. [in Russian]
5. Shishkova V.N., Remennik A.Iu., Valiaeva V.N. i dr. Izuchenie assotsiatsii polimorfnykh variantov genov lipidnogo i uglevodnogo obmenov, sosudistogo vospaleniia i neirotransmitternykh sistem s razvitiem pervogo ishemicheskogo insul'ta. Kardiovask. terapiia i profilaktika. 2017; 16 (5): 27–33. [in Russian]
6. Shishkova V.N., Adasheva T.V, Remennik A.Iu. i dr. Prognosticheskaia znachimost' kliniko-antropometricheskikh, biokhimicheskikh, metabolicheskikh, sosudisto-vospalitel'nykh i molekuliarno-geneticheskikh markerov v razvitii pervogo ishemicheskogo insul'ta. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2018; 2: 4–11. [in Russian]
7. Shishkova V.N., Adasheva T.V., Remennik A.Iu. i dr. Prediktory razvitiia povtornogo ishemicheskogo insul'ta. Vrach. 2018; 29 (2): 38–44. DOI: 10.29296/25877305-2018-02-10 [in Russian]
8. Foniakin A.V., Geraskina L.A. Profilaktika ishemicheskogo insul'ta. Rekomendatsii po antitromboticheskoi terapii. Pod red. Z.A.Suslinoi. M.: IMA-Press, 2014. [in Russian]
9. Furie K, Kasner S, Adams R et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2011; 42: 227–76.
10. Goldstein L, Bushnell Ch, Adams R et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–84.
11. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. The European Stroke Organization (ESO), 2008. http://www.eso-stroke.org
12. Jauch E, Saver J, Adams H et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke 2013; 44: 870–947.
14. Kernan W et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160–236.
15. Intercollegiate Stroke Working Party. National clinical guideline for stroke, 4th ed. London: Royal College of Physicians, 2012.
16. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34 (11): 2741–8.
17. Klinicheskie rekomendatsii “Diagnostika i lechenie arterial'noi gipertenzii” Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii, 2013. [in Russian]
18. Rekomendatsii EOK/EOA po diagnostike i lecheniiu dislipidemii 2016. Ros. kardiol. zhurn. 2017; 5 (145): 7–77. [in Russian]
19. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation, 2011.
20. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 8-i vyp. Sakharnyi diabet. 2017; 20 (1S): 1–112. [in Russian]
21. Stamler J, Vaccaro O, Neaton J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16 (2): 434–44.
22. Shishkova V.N. Vzaimosviaz' razvitiia metabolicheskikh i kognitivnykh narushenii u patsientov s sakharnym diabetom, prediabetom i metabolicheskim sindromom. Neurology and Rheumatology (Suppl. Consilium Medicum). 2010; 1: 36–43. [in Russian]
23. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 17 (3).
24. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in atrial fibrillation: a systematic review. Neurology 2007; 69 (6): 546–54.
25. Camm A, Lip G, de Caterina R et al. 2012 focused up date of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719–47.
26. Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh, 2017. [in Russian]
Авторы
В.Н.Шишкова
ГБУЗ «Центр патологии речи и нейрореабилитации» Департамента здравоохранения г. Москвы. 109240, Россия, Москва, ул. Николоямская, д. 20
veronika-1306@mail.ru
ГБУЗ «Центр патологии речи и нейрореабилитации» Департамента здравоохранения г. Москвы. 109240, Россия, Москва, ул. Николоямская, д. 20
veronika-1306@mail.ru
________________________________________________
V.N.Shishkova
Center for Speech Pathology and Neurorehabilitation of the Department of Health of Moscow. 109240, Russian Federation, Moscow, ul. Nikoloyamskaia, d. 20
veronika-1306@mail.ru
Center for Speech Pathology and Neurorehabilitation of the Department of Health of Moscow. 109240, Russian Federation, Moscow, ul. Nikoloyamskaia, d. 20
veronika-1306@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.